H. R. 6344—26
‘‘(1) PROGRAM.—The Chief Scientist, with the advice and 
counsel of experts from State, local, and tribal law enforcement 
agencies, shall be responsible to the Director for coordination 
and implementation of a counterdrug technology transfer pro-
gram. 
‘‘(2) PURPOSE.—The purpose of the Technology Transfer 
Program shall be for the Counterdrug Technology Assessment 
Center to transfer technology and associated training directly 
to State, local, and tribal law enforcement agencies. 
‘‘(3) PRIORITY OF RECEIPTS.—Transfers shall be made in 
priority order based on—
‘‘(A) the need of potential recipients for such tech-
nology; 
‘‘(B) the effectiveness of the technology to enhance 
current counterdrug activities of potential recipients; and 
‘‘(C) the ability and willingness of potential recipients 
to evaluate transferred technology. 
‘‘(4) AGREEMENT AUTHORITY.—The Director may enter into 
an agreement with the Secretary of Homeland Security to 
transfer technology with both counterdrug and homeland secu-
rity applications to State, local, and tribal law enforcement 
agencies on a reimbursable basis. 
‘‘(5) REPORT.—On or before July 1 of each year, the Director 
shall submit a report to the appropriate congressional commit-
tees that addresses the following: 
‘‘(A) The number of requests received during the pre-
vious 12 months, including the identity of each requesting 
agency and the type of technology requested. 
‘‘(B) The number of requests fulfilled during the pre-
vious 12 months, including the identity of each recipient 
agency and the type of technology transferred. 
‘‘(C) A summary of the criteria used in making the 
determination on what requests were funded and what 
requests were not funded, except that such summary shall 
not include specific information on any individual requests. 
‘‘(D) A general assessment of the future needs of the 
program, based on expected changes in threats, expected 
technologies, and likely need from potential recipients. 
‘‘(E) An assessment of the effectiveness of the tech-
nologies transferred, based in part on the evaluations pro-
vided by the recipients, with a recommendation whether 
the technology should continue to be offered through the 
program.’’. 
(c) ASSISTANCE FROM SECRETARY OF HOMELAND SECURITY.—
Section 708(d) (21 U.S.C. 1707(d)) is amended by inserting ‘‘, the 
Secretary of Homeland Security,’’ after ‘‘The Secretary of Defense’’. 
TITLE V—NATIONAL YOUTH MEDIA 
CAMPAIGN 
SEC. 501. NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN. 
(a) IN GENERAL.—Section 709 (21 U.S.C. 1708) is amended 
to read as follows:
H. R. 6344—27
‘‘SEC. 709. NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN. 
‘‘(a) IN GENERAL.—The Director shall conduct a national youth 
anti-drug media campaign (referred to in this subtitle as the 
‘national media campaign’) in accordance with this section for the 
purposes of—
‘‘(1) preventing drug abuse among young people in the 
United States; 
‘‘(2) increasing awareness of adults of the impact of drug 
abuse on young people; and 
‘‘(3) encouraging parents and other interested adults to 
discuss with young people the dangers of illegal drug use. 
‘‘(b) USE OF FUNDS.—
‘‘(1) IN GENERAL.—Amounts made available to carry out 
this section for the national media campaign may only be 
used for the following: 
‘‘(A) The purchase of media time and space, including 
the strategic planning for, and accounting of, such pur-
chases. 
‘‘(B) Creative and talent costs, consistent with para-
graph (2)(A). 
‘‘(C) Advertising production costs. 
‘‘(D) Testing and evaluation of advertising. 
‘‘(E) Evaluation of the effectiveness of the national 
media campaign. 
‘‘(F) The negotiated fees for the winning bidder on 
requests for proposals issued either by the Office or its 
designee to enter into contracts to carry out activities 
authorized by this section. 
‘‘(G) Partnerships with professional and civic groups, 
community-based 
organizations, 
including 
faith-based 
organizations, and government organizations related to the 
national media campaign. 
‘‘(H) Entertainment industry outreach, interactive out-
reach, media projects and activities, public information, 
news media outreach, and corporate sponsorship and 
participation. 
‘‘(I) Operational and management expenses. 
‘‘(2) SPECIFIC REQUIREMENTS.—
‘‘(A) CREATIVE SERVICES.—
‘‘(i) In using amounts for creative and talent costs 
under paragraph (1)(B), the Director shall use creative 
services donated at no cost to the Government 
(including creative services provided by the Partner-
ship for a Drug-Free America) wherever feasible and 
may only procure creative services for advertising—
‘‘(I) responding to high-priority or emergent 
campaign needs that cannot timely be obtained 
at no cost; or 
‘‘(II) intended to reach a minority, ethnic, or 
other special audience that cannot reasonably be 
obtained at no cost; or 
‘‘(III) the Director determines that the Part-
nership for a Drug-Free America is unable to pro-
vide, pursuant to subsection (d)(2)(B). 
‘‘(ii) Subject to the availability of appropriations, 
no more than $1,500,000 may be expended under this 
section each fiscal year on creative services, except
H. R. 6344—28
that the Director may expend up to $2,000,000 in 
a fiscal year on creative services to meet urgent needs 
of the national media campaign with advance approval 
from the Committee on Appropriations of the Senate 
and of the House of Representatives upon a showing 
of the circumstances causing such urgent needs of the 
national media campaign. 
‘‘(B) TESTING
AND
EVALUATION
OF
ADVERTISING.—In 
using amounts for testing and evaluation of advertising 
under paragraph (1)(D), the Director shall test all 
advertisements prior to use in the national media campaign 
to ensure that the advertisements are effective and meet 
industry-accepted standards. The Director may waive this 
requirement for advertisements using no more than 10 
percent of the purchase of advertising time purchased 
under this section in a fiscal year and no more than 10 
percent of the advertising space purchased under this sec-
tion in a fiscal year, if the advertisements respond to 
emergent and time-sensitive campaign needs or the 
advertisements will not be widely utilized in the national 
media campaign. 
‘‘(C) EVALUATION
OF
EFFECTIVENESS
OF
MEDIA
CAM-
PAIGN.—In using amounts for the evaluation of the 
effectiveness of the national media campaign under para-
graph (1)(E), the Director shall—
‘‘(i) designate an independent entity to evaluate 
by April 20 of each year the effectiveness of the 
national media campaign based on data from—
‘‘(I) the Monitoring the Future Study published 
by the Department of Health and Human Services; 
‘‘(II) the Attitude Tracking Study published 
by the Partnership for a Drug-Free America; 
‘‘(III) the National Household Survey on Drug 
Abuse; and 
‘‘(IV) other relevant studies or publications, 
as determined by the Director, including tracking 
and evaluation data collected according to mar-
keting and advertising industry standards; and 
‘‘(ii) ensure that the effectiveness of the national 
media campaign is evaluated in a manner that enables 
consideration of whether the national media campaign 
has contributed to reduction of illicit drug use among 
youth and such other measures of evaluation as the 
Director determines are appropriate. 
‘‘(3) PURCHASE OF ADVERTISING TIME AND SPACE.—Subject 
to the availability of appropriations, for each fiscal year, not 
less than 77 percent of the amounts appropriated under this 
section shall be used for the purchase of advertising time and 
space for the national media campaign, subject to the following 
exceptions: 
‘‘(A) In any fiscal year for which less than $125,000,000 
is appropriated for the national media campaign, not less 
than 72 percent of the amounts appropriated under this 
section shall be used for the purchase of advertising time 
and space for the national media campaign. 
‘‘(B) In any fiscal year for which more than 
$195,000,000 is appropriated under this section, not less
H. R. 6344—29
than 82 percent shall be used for advertising production 
costs and the purchase of advertising time and space for 
the national media campaign. 
‘‘(c) ADVERTISING.—In carrying out this section, the Director 
shall ensure that sufficient funds are allocated to meet the stated 
goals of the national media campaign. 
‘‘(d) DIVISION OF RESPONSIBILITIES AND FUNCTIONS UNDER THE 
PROGRAM.—
‘‘(1) IN GENERAL.—The Director, in consultation with the 
Partnership for a Drug-Free America, shall determine the 
overall purposes and strategy of the national media campaign. 
‘‘(2) RESPONSIBILITIES.—
‘‘(A) DIRECTOR.—The Director shall be responsible for 
implementing a focused national media campaign to meet 
the purposes set forth in subsection (a), and shall approve—
‘‘(i) the strategy of the national media campaign; 
‘‘(ii) all advertising and promotional material used 
in the national media campaign; and 
‘‘(iii) the plan for the purchase of advertising time 
and space for the national media campaign. 
‘‘(B) THE PARTNERSHIP FOR A DRUG-FREE AMERICA.—
The Director shall request that the Partnership for a Drug-
Free America—
‘‘(i) develop and recommend strategies to achieve 
the goals of the national media campaign, including 
addressing national and local drug threats in specific 
regions or States, such as methamphetamine and 
ecstasy; 
‘‘(ii) create all advertising to be used in the national 
media campaign, except advertisements that are—
‘‘(I) provided by other nonprofit entities pursu-
ant to subsection (f); 
‘‘(II) intended to respond to high-priority or 
emergent campaign needs that cannot timely be 
obtained at no cost (not including production costs 
and talent reuse payments), provided that any 
such advertising material is reviewed by the Part-
nership for a Drug-Free America; 
‘‘(III) intended to reach a minority, ethnic, or 
other special audience that cannot be obtained at 
no cost (not including production costs and talent 
reuse payments), provided that any such adver-
tising material is reviewed by the Partnership for 
a Drug-Free America; or 
‘‘(IV) any other advertisements that the 
Director determines that the Partnership for a 
Drug-Free America is unable to provide or if the 
Director determines that another entity is more 
appropriate, subject to the requirements of sub-
section (b)(2)(A). 
If the Director determines that another entity is more 
appropriate under clause (ii)(IV), the Director shall notify 
Congress, through the committees of jurisdiction in the 
House and Senate, in writing, not less than 30 days prior 
to contracting with a party other than the Partnership 
for a Drug-Free America.
H. R. 6344—30
‘‘(C) MEDIA BUYING CONTRACTOR.—The Director shall 
enter into a contract with a media buying contractor to 
plan and purchase advertising time and space for the 
national media campaign. The media buying contractor 
shall not provide any other service or material, or conduct 
any other function or activity which the Director deter-
mines should be provided by the Partnership for a Drug-
Free America. 
‘‘(e) PROHIBITIONS.—None of the amounts made available under 
subsection (b) may be obligated or expended for any of the following: 
‘‘(1) To supplant current anti-drug community-based coali-
tions. 
‘‘(2) To supplant pro bono public service time donated by 
national and local broadcasting networks for other public 
service campaigns. 
‘‘(3) For partisan political purposes, or express advocacy 
in support of or to defeat any clearly identified candidate, 
clearly identified ballot initiative, or clearly identified legisla-
tive or regulatory proposal. 
‘‘(4) To fund advertising that features any elected officials, 
persons seeking elected office, cabinet level officials, or other 
Federal officials employed pursuant to section 213 of Schedule 
C of title 5, Code of Federal Regulations. 
‘‘(5) To fund advertising that does not contain a primary 
message intended to reduce or prevent illicit drug use. 
‘‘(6) To fund advertising containing a primary message 
intended to promote support for the media campaign or private 
sector contributions to the media campaign. 
‘‘(f) MATCHING REQUIREMENT.—
‘‘(1) IN
GENERAL.—Amounts made available under sub-
section (b) for media time and space shall be matched by 
an equal amount of non-Federal funds for the national media 
campaign, or be matched with in-kind contributions of the 
same value. 
‘‘(2) NO-COST
MATCH
ADVERTISING
DIRECT
RELATIONSHIP 
REQUIREMENT.—The Director shall ensure that at least 70 per-
cent of no-cost match advertising provided directly relates to 
substance abuse prevention consistent with the specific pur-
poses of the national media campaign, except that in any fiscal 
year in which less than $125,000,000 is appropriated to the 
national media campaign, the Director shall ensure that at 
least 85 percent of no-cost match advertising directly relates 
to substance abuse prevention consistent with the specific pur-
poses of the national media campaign. 
‘‘(3) NO-COST MATCH ADVERTISING NOT DIRECTLY RELATED.—
The Director shall ensure that no-cost match advertising that 
does not directly relate to substance abuse prevention consistent 
with the purposes of the national media campaign includes 
a clear anti-drug message. Such message is not required to 
be the primary message of the match advertising. 
‘‘(g) FINANCIAL
AND
PERFORMANCE
ACCOUNTABILITY.—The 
Director shall cause to be performed—
‘‘(1) audits and reviews of costs of the national media 
campaign pursuant to section 304C of the Federal Property 
and Administrative Services Act of 1949 (41 U.S.C. 254d); and
H. R. 6344—31
‘‘(2) an audit to determine whether the costs of the national 
media campaign are allowable under section 306 of such Act 
(41 U.S.C. 256). 
‘‘(h) REPORT TO CONGRESS.—The Director shall submit on an 
annual basis a report to Congress that describes—
‘‘(1) the strategy of the national media campaign and 
whether specific objectives of the media campaign were accom-
plished; 
‘‘(2) steps taken to ensure that the national media campaign 
operates in an effective and efficient manner consistent with 
the overall strategy and focus of the national media campaign; 
‘‘(3) plans to purchase advertising time and space; 
‘‘(4) policies and practices implemented to ensure that Fed-
eral funds are used responsibly to purchase advertising time 
and space and eliminate the potential for waste, fraud, and 
abuse; and 
‘‘(5) all contracts entered into with a corporation, partner-
ship, or individual working on behalf of the national media 
campaign. 
‘‘(i) LOCAL TARGET REQUIREMENT.—The Director shall, to the 
maximum extent feasible, use amounts made available under this 
section for media that focuses on, or includes specific information 
on, prevention or treatment resources for consumers within specific 
local areas. 
‘‘(j) PREVENTION OF MARIJUANA USE.—
‘‘(1) FINDINGS.—The Congress finds the following: 
‘‘(A) 60 percent of adolescent admissions for drug treat-
ment are based on marijuana use. 
‘‘(B) Potency levels of contemporary marijuana, particu-
larly hydroponically grown marijuana, are significantly 
higher than in the past, rising from under 1 percent of 
THC in the mid-1970s to as high as 30 percent today. 
‘‘(C) Contemporary research has demonstrated that 
youths smoking marijuana early in life may be up to 5 
times more likely to use hard drugs. 
‘‘(D) Contemporary research has demonstrated clear 
detrimental effects in adolescent educational achievement 
resulting from marijuana use. 
‘‘(E) Contemporary research has demonstrated clear 
detrimental effects in adolescent brain development 
resulting from marijuana use. 
‘‘(F) An estimated 9,000,000 Americans a year drive 
while under the influence of illegal drugs, including mari-
juana. 
‘‘(G) Marijuana smoke contains 50 to 70 percent more 
of certain cancer causing chemicals than tobacco smoke. 
‘‘(H) Teens who use marijuana are up to 4 times more 
likely to have a teen pregnancy than teens who have not. 
‘‘(I) Federal law enforcement agencies have identified 
clear links suggesting that trade in hydroponic marijuana 
facilitates trade by criminal organizations in hard drugs, 
including heroin. 
‘‘(J) Federal law enforcement agencies have identified 
possible links between trade in cannabis products and 
financing for terrorist organizations. 
‘‘(2) EMPHASIS ON PREVENTION OF YOUTH MARIJUANA USE.—
In conducting advertising and activities otherwise authorized
H. R. 6344—32
under this section, the Director may emphasize prevention 
of youth marijuana use. 
‘‘(k) PREVENTION
OF METHAMPHETAMINE ABUSE
AND OTHER 
EMERGING DRUG ABUSE THREATS.—
‘‘(1) REQUIREMENT TO USE 10 PERCENT OF FUNDS FOR METH-
AMPHETAMINE ABUSE PREVENTION.—The Director shall ensure 
that, of the amounts appropriated under this section for the 
national media campaign for a fiscal year, not less than 10 
percent shall be expended solely for the activities described 
in subsection (b)(1) with respect to advertisements specifically 
intended to reduce the use of methamphetamine. 
‘‘(2) AUTHORITY
TO
USE
FUNDS
FOR
OTHER
DRUG
ABUSE 
UPON
CERTIFICATION
THAT
METHAMPHETAMINE
ABUSE
FELL 
DURING FISCAL YEAR 2007.—With respect to fiscal year 2008 
and any fiscal year thereafter, if the Director certifies in writing 
to Congress that domestic methamphetamine laboratory sei-
zures (as reported to the El Paso Intelligence Center of the 
Drug Enforcement Administration) decreased to at least 75 
percent of the 2006 level, or the Director has documented 
a highly, statistically significant increase in a specific drug, 
from a baseline determined by locally collected data, that can 
be defined as a local drug crisis, the Director may apply para-
graph (1)(A) for that fiscal year with respect to advertisements 
specifically intended to reduce the use of such other drugs. 
‘‘(l) AUTHORIZATION OF APPROPRIATIONS.—There is authorized 
to be appropriated to the Office to carry out this section, 
$195,000,000 for each of fiscal years 2007 and 2008 and 
$210,000,000 for each of fiscal years 2009 through 2011.’’. 
(b) REPEAL OF SUPERSEDED PROVISIONS.—The Drug-Free Media 
Campaign Act of 1998 (21 U.S.C. 1801 et seq.) is repealed. 
TITLE VI—AUTHORIZATIONS AND 
EXTENSION OF TERMINATION DATE 
SEC. 601. AUTHORIZATION OF APPROPRIATIONS. 
Section 714 is amended—
(1) by striking ‘‘title,’’ and inserting ‘‘title except activities 
otherwise specified,’’; and 
(2) by striking ‘‘1999 through 2003’’ and inserting ‘‘2006 
through 2010’’. 
SEC. 602. EXTENSION OF TERMINATION DATE. 
Section 715(a) is amended by striking ‘‘September 30, 2003, 
this title and the amendments made by this title’’ and inserting 
‘‘September 30, 2010, this title and the amendments made to this 
title’’. 
TITLE VII—ANTI-DOPING AGENCY 
SEC. 701. DESIGNATION OF UNITED STATES ANTI-DOPING AGENCY. 
(a) DEFINITIONS.—In this title: 
(1) UNITED STATES OLYMPIC COMMITTEE.—The term ‘‘United 
States Olympic Committee’’ means the organization established 
by the ‘‘Ted Stevens Olympic and Amateur Sports Act’’ (36 
U.S.C. 220501 et seq.).
H. R. 6344—33
(2) AMATEUR ATHLETIC COMPETITION.—The term ‘‘amateur 
athletic competition’’ means a contest, game, meet, match, tour-
nament, regatta, or other event in which amateur athletes 
compete (36 U.S.C. 220501(b)(2)). 
(3) AMATEUR ATHLETE.—The term ‘‘amateur athlete’’ means 
an athlete who meets the eligibility standards established by 
the national governing body or paralympic sports organization 
for the sport in which the athlete competes (36 U.S.C. 
22501(b)(1)). 
(4) GENE DOPING.—The term ‘‘gene doping’’ means the non-
therapeutic use of cells, genes, genetic elements, or of the 
modulation of gene expression, having the capacity to enhance 
athletic performance. 
(b) IN
GENERAL.—The United States Anti-Doping Agency 
shall—
(1) serve as the independent anti-doping organization for 
the amateur athletic competitions recognized by the United 
States Olympic Committee; 
(2) ensure that athletes participating in amateur athletic 
activities recognized by the United States Olympic Committee 
are prevented from using performance-enhancing drugs, or 
performance-enhancing genetic modifications accomplished 
through gene-doping; 
(3) implement anti-doping education, research, testing, and 
adjudication programs to prevent United States Amateur Ath-
letes participating in any activity recognized by the United 
States Olympic Committee from using performance-enhancing 
drugs, or performance-enhancing genetic modifications accom-
plished through gene-doping; 
(4) serve as the United States representative responsible 
for coordination with other anti-doping organizations coordi-
nating amateur athletic competitions recognized by the United 
States Olympic Committee to ensure the integrity of athletic 
competition, the health of the athletes and the prevention of 
use of performance-enhancing drugs, or performance-enhancing 
genetic modifications accomplished through gene-doping by 
United States amateur athletes; and 
(5) permanently include ‘‘gene doping’’ among any list of 
prohibited substances adopted by the Agency. 
SEC. 702. RECORDS, AUDIT, AND REPORT. 
(a) RECORDS.—The United States Anti-Doping Agency shall 
keep correct and complete records of account. 
(b) REPORT.—The United States Anti-Doping Agency shall 
submit an annual report to Congress which shall include—
(1) an audit conducted and submitted in accordance with 
section 10101 of title 36, United States Code; and 
(2) a description of the activities of the agency. 
SEC. 703. AUTHORIZATION OF APPROPRIATIONS. 
There are authorized to be appropriated to the United States 
Anti-Doping Agency—
(1) for fiscal year 2007, $9,700,000; 
(2) for fiscal year 2008, $10,300,000; 
(3) for fiscal year 2009, $10,600,000; 
(4) for fiscal year 2010, $11,000,000; and 
(5) for fiscal year 2011, $11,500,000.
H. R. 6344—34
TITLE VIII—DRUG-FREE COMMUNITIES 
SEC. 801. REAUTHORIZATION. 
(a) IN GENERAL.—Section 1024(a) of the Drug-Free Commu-
nities Act of 1997 (21 U.S.C. 1524(a)) is amended—
(1) in paragraph (9), by striking ‘‘and’’ after the semicolon; 
(2) in paragraph (10), by striking the period and inserting 
a semicolon; and 
(3) by adding at the end the following: 
‘‘(11) $109,000,000 for fiscal year 2008; 
‘‘(12) $114,000,000 for fiscal year 2009; 
‘‘(13) $119,000,000 for fiscal year 2010; 
‘‘(14) $124,000,000 for fiscal year 2011; and 
‘‘(15) $129,000,000 for fiscal year 2012.’’. 
(b) ADMINISTRATION COSTS.—Section 1024(b) of the Drug-Free 
Communities Act of 1997 (21 U.S.C. 1524(b)) is amended to read 
as follows: 
‘‘(b) ADMINISTRATIVE COSTS.—
‘‘(1) LIMITATION.—Not more than 3 percent of the funds 
appropriated for this chapter may be used by the Office of 
National Drug Control Policy to pay for administrative costs 
associated with their responsibilities under the chapter. 
‘‘(2) DESIGNATED AGENCY.—The agency delegated to carry 
out this program under section 1031(d) may use up to 5 percent 
of the funds allocated for grants under this chapter for adminis-
trative costs associated with carrying out the program.’’. 
SEC. 802. SUSPENSION OF GRANTS. 
(a) IN GENERAL.—Section 1032(b) of the Drug-Free Commu-
nities Act of 1997 (21 U.S.C. 1532(b)) is amended by adding at 
the end the following: 
‘‘(4) PROCESS
FOR
SUSPENSION.—A grantee shall not be 
suspended or terminated under paragraph (1)(A)(ii), (2)(A)(iii), 
or (3)(E) unless that grantee is afforded a fair, timely, and 
independent appeal prior to such suspension or termination.’’. 
(b) REPORT TO CONGRESS.—Not later than 60 days after the 
date of enactment of this Act, the Director of the Office of National 
Drug Control Policy shall submit to Congress a report detailing 
the appeals process required by section 1032(b)(4) of the Drug-
Free Communities Act of 1997, as added by subsection (a). 
SEC. 803. GRANT AWARD INCREASE. 
Subsections (b)(1)(A)(iv), (b)(2)(C)(i), and (b)(3)(F) of section 
1032 of the Drug-Free Communities Act of 1997 (21 U.S.C. 1532) 
are amended by striking ‘‘$100,000’’ and inserting ‘‘$125,000’’. 
SEC. 804. PROHIBITION ON ADDITIONAL ELIGIBILITY CRITERIA. 
Section 1032(a) of the Drug-Free Communities Act of 1997 
(21 U.S.C. 1532(a)) is amended by adding at the end the following: 
‘‘(7) ADDITIONAL CRITERIA.—The Director shall not impose 
any eligibility criteria on new applicants or renewal grantees 
not provided in this chapter.’’. 
SEC. 805. NATIONAL COMMUNITY ANTI-DRUG COALITION INSTITUTE. 
Section 4 of Public Law 107–82 (21 U.S.C. 1521 note), reauthor-
izing the Drug-Free Communities Support Program, is amended—
(1) by amending subsection (a) to read as follows: